drugset / Trial / NCT01438580

The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial Fibrillation

NCT01438580

Phase 4 Completed 260 enrolled Nanjing Medical University
RandomizedParallel-groupSingle-blindTreatment

Summary

Current guidelines recommend standard warfarin anticoagulation international normalized ratio (INR) goal of 2.0-3.0 in adults with non valvular atrial fibrillation (NVAF). The investigators hypothesized that low-intensity warfarin (INR 1.5-2.0) has the same effectiveness and better security in elderly patients (\>75) with NVAF.

Timeline

Start
2010-01
Primary completion
2012-01
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 100 mg
Subject Warfarin Small molecule

Indications